Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 2012; Volume 81,Issue 5

Minireview

  • You have access
    mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
    Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
    Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604

Articles

  • You have access
    Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
    Sarah-Jane Watson, Alastair J. H. Brown and Nicholas D. Holliday
    Molecular Pharmacology May 2012, 81 (5) 631-642; DOI: https://doi.org/10.1124/mol.111.077388
  • You have access
    Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
    F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
    Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  • You have access
    Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
    Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
    Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976
  • You have access
    The Aryl Hydrocarbon Receptor Contributes to the Proliferation of Human Medulloblastoma Cells
    Daniel P. Dever and Lisa A. Opanashuk
    Molecular Pharmacology May 2012, 81 (5) 669-678; DOI: https://doi.org/10.1124/mol.111.077305
  • You have access
    Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
    J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
    Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  • You have access
    Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
    Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
    Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
  • You have access
    Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
    Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
    Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
  • You have access
    A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
    JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
    Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026
  • You have access
    Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
    Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
    Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  • You have access
    Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
    Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
    Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339
  • You have access
    Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
    Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
    Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
  • You have access
    Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
    Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
    Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 81 (5)
Molecular Pharmacology
Vol. 81, Issue 5
1 May 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics